Transplant Diagnostics Market - Global Industry Analysis

Transplant Diagnostics Market by Technology, Transplant Type, and End User – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2030

7.3%

CAGR (2024-2030)

4.3 USD Bn.

Market Size

301

Report Pages

158

Market Tables

Overview

Global Transplant Diagnostics Market is expected to grow at a CAGR of 7.3% during the forecast period. Global Transplant Diagnostics Market is expected to reach USD 6.7 Billion by 2030.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report

Transplant Diagnostics Market Drivers and Restrains

Transplant diagnostics helps in checking the histocompatibility between patient and donor, which further reduces the chances of organ rejection thereby increasing the reliability of the organ transplantation. The diagnostics devices help to find out the various markers found on the outer surface of cells which regulate the recognition and rejection of foreign body.

Technological advancements, rising incidence of chronic diseases, and increased R&D activities are key factors driving the global Transplant Diagnostics market. Increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to drive the transplant diagnostic market in the U.S. during the forecast period. Organ shortage for transplant procedures, challenges in sequencing HLA, treatment cost and lack of awareness are considered to be the major restraint to global market.

Transplant Diagnostics Market Key segmentation

Global Transplant Diagnostics Market is segmented by Type and Technology. By type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. Further Solid organ segment is sub-divided in to Lung Transplantation, Liver Transplantation, Kidney Transplantation and Heart Transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2023.

Increasing number of solid organ transplantation procedures, supportive government regulations to enhance organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation. Based on technology, the market is segmented in to Molecular Assays and Non-Molecular Assays. Molecular assay segment is further sub-categorized in to Sequencing-Based Molecular Assays and PCR-Based Molecular Assays. The molecular assay technology segment is anticipated to hold the largest share of this market thanks to increasing capital for the development of advanced transplant diagnostics products.

Market Regional Analysis

By region, the global transplant diagnostic market has been categorized as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds largest share of global Transplant Diagnostics market in terms of revenue during forecast period. Because of rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period.

China dominated the transplant diagnostic market in Asia Pacific whereas the market in India is estimated to expand at a significant CAGR during the forecast period. Increasing awareness as well as affordability of transplantation procedures are factors responsible for growth of transplant diagnostic market in the Asia Pacific.

The objective of the report is to present comprehensive analysis of Global Transplant Diagnostics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Transplant Diagnostics Market dynamics, structure by analyzing the market segments, and project the Global Transplant Diagnostics Market size. Clear representation of competitive analysis of key players by Transplant Diagnostics Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Transplant Diagnostics Market make the report investor’s guide.

Transplant Diagnostics Industry Ecosystem

Scope of Global Transplant Diagnostics Market : Inquire before buying

Global Transplant Diagnostics Market
Report Coverage	Details
Base Year:	2023	Forecast Period:	2024-2030
Historical Data:	2018 to 2023	Market Size in 2023:	USD 4.3 Billion
Forecast Period 2024 to 2030 CAGR:	7.3 %	Market Size in 2030:	USD 6.7 Billion
Segments Covered:	by Technology	Molecular Assays Sequencing based molecular Assays Non-Molecular Assays
	by Transplant Type	Solid Organ Transplantation Soft Tissue Transplantation Stem Cell Transplantation
	by End User	Hospitals & Transplant Centers Research Laboratories & Academic Institutes Independent Reference Laboratories Diagnostic Applications

Transplant Diagnostics Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Transplant Diagnostics Market Key Players are:

1. Thermo Fisher Scientific, Inc.,
2. Illumina, Inc.,
3. F. Hoffmann La-Roche AG.,
4. Abbott Laboratories, Inc.
5. Qiagen N.V.
6. Bio-Rad Laboratories, Inc.,
7. Siemens Healthineers (Siemens AG),
8. Becton,
9. Dickinson, and Company,
10. Immucor, Inc.,
11. Qiagen N.V.,
12. Agilent Technologies
13. Cylex Inc.
14. LXN Corporation
15. Alpha Laboratories
16. Horiba Medical
17. Laboratory Corporation of America Holdings
18. Randox Laboratories Ltd
19. Thermo Fisher Scientific Inc.
20. Otsuka Holdings Co Ltd.
21. Medtronic
22. Novartis AG
23. Pfizer Inc.
24. Sanofi
25. AbbVie Inc.
26. Stryker
27. Zimmer Biomet

Frequently Asked questions

1. Which region has the largest share in Global Transplant Diagnostics Market?
Ans: Asia Pacific region held the highest share in 2023.

2. What is the growth rate of Global Transplant Diagnostics Market?
Ans: The Global Transplant Diagnostics Market is growing at a CAGR of 7.3% during forecasting period 2024-2030.

3. What is scope of the Global Transplant Diagnostics Market report?
Ans: Global Transplant Diagnostics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Transplant Diagnostics Market?
Ans: The important key players in the Global Transplant Diagnostics Market are – Cerus Corporation, Fresenius Medical Care, Asahi Kasei Medical, Fenwal, Kawasumi Laboratories, Haemonetics Corporation, Terumo Bct, Kaneka Corporation, Hemacare Corporation, Therakos.

5. What is the study period of this Market?
Ans: The Global Transplant Diagnostics Market is studied from 2023 to 2030.

1. Transplant Diagnostics Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.2.1. Transplant Diagnostics: Market Segmentation 1.2.2. Region Covered 1.3. Executive Summary 2. Global Transplant Diagnostics Market : Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Key Development 2.5.6. Market Share 2.6. Industry Ecosystem 2.6.1. Key players in the Transplant Diagnostics ecosystem 2.6.2. Role of companies in the Transplant Diagnostics ecosystem 2.7. Upcoming Technological and Advancement Initiatives by Key Players 2.8. Market Structure 2.8.1. Market Leaders 2.8.2. Market Followers 2.8.3. Emerging Players 2.9. Consolidation of the Market 2.9.1. Strategic Initiatives and Developments 2.9.2. Mergers and Acquisitions 2.9.3. Collaborations and Partnerships 2.9.4. Product Launches and Innovations 2.10. Pricing Analysis: Average Selling Price of Transplant Diagnostics Offered by Key Players in the Market 3. Transplant Diagnostics Market : Dynamics 3.1. Transplant Diagnostics Market Trends by Region 3.1.1. North America Transplant Diagnostics Market Trends 3.1.2. Europe Transplant Diagnostics Market Trends 3.1.3. Asia Pacific Transplant Diagnostics Market Trends 3.1.4. South America Transplant Diagnostics Market Trends 3.1.5. Middle East & Africa (MEA) Transplant Diagnostics Market Trends 3.2. Transplant Diagnostics Market Dynamics by Region 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. Supply Chain Analysis 3.5. Value Chain Analysis 3.6. Treads and Disruption Impacting Customer Business 3.6.1. Treads and Disruption Impacting Customer Business 3.7. Technological Analysis 3.8. Ecosystem Analysis 3.8.1. Transplant Diagnostics Market: Ecosystem 3.9. Key Stakeholder and Buying Criteria 3.9.1. Influence of Stakeholders on the Buying Process for the Top Applications 3.9.2. Key Buying Criteria for Top Applications 3.10. Regulatory Landscape 3.10.1. Regulation by Region 3.10.2. Tariff and Taxes 3.10.3. Regulatory Bodies, Government agencies, and other organization by Region 3.11. Patent Analysis 3.11.1. Top 10 Patent Holders 3.11.2. Top 10 Companies with Highest Number of Patents 3.11.3. Patent Registration Analysis 3.11.4. Number of Patents Granted Still 2024 4. Trade Data Analysis: 4.1.1. Import/ Export of Transplant Diagnostics 5. Transplant Diagnostics Market : Global Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 5.1. Global Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 5.1.1. Molecular Assays 5.1.2. Sequencing based molecular Assays 5.1.3. Non-Molecular Assays 5.2. Global Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 5.2.1. Solid Organ Transplantation 5.2.2. Soft Tissue Transplantation 5.2.3. Stem Cell Transplantation 5.3. Global Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 5.3.1. Hospitals & Transplant Centers 5.3.2. Research Laboratories & Academic Institutes 5.3.3. Independent Reference Laboratories 5.3.4. Diagnostic Applications 5.4. Global Transplant Diagnostics Market Size and Forecast, by Region (2023-2030) 5.4.1. North America 5.4.2. Europe 5.4.3. Asia Pacific 5.4.4. South America 5.4.5. MEA 6. North America Transplant Diagnostics Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 6.1. North America Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 6.1.1. Molecular Assays 6.1.2. Sequencing based molecular Assays 6.1.3. Non-Molecular Assays 6.2. North America Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 6.2.1. Solid Organ Transplantation 6.2.2. Soft Tissue Transplantation 6.2.3. Stem Cell Transplantation 6.3. North America Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 6.3.1. Hospitals & Transplant Centers 6.3.2. Research Laboratories & Academic Institutes 6.3.3. Independent Reference Laboratories 6.3.4. Diagnostic Applications 6.4. North America Transplant Diagnostics Market Size and Forecast, by Country (2023-2030) 6.4.1. United States 6.4.1.1. United States Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 6.4.1.1.1. Molecular Assays 6.4.1.1.2. Sequencing based molecular Assays 6.4.1.1.3. Non-Molecular Assays 6.4.1.2. United States Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 6.4.1.2.1. Solid Organ Transplantation 6.4.1.2.2. Soft Tissue Transplantation 6.4.1.2.3. Stem Cell Transplantation 6.4.1.3. United States Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 6.4.1.3.1. Hospitals & Transplant Centers 6.4.1.3.2. Research Laboratories & Academic Institutes 6.4.1.3.3. Independent Reference Laboratories 6.4.1.3.4. Diagnostic Applications 6.4.2. Canada 6.4.2.1. Canada Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 6.4.2.1.1. Molecular Assays 6.4.2.1.2. Sequencing based molecular Assays 6.4.2.1.3. Non-Molecular Assays 6.4.2.2. Canada Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 6.4.2.2.1. Solid Organ Transplantation 6.4.2.2.2. Soft Tissue Transplantation 6.4.2.2.3. Stem Cell Transplantation 6.4.2.3. Canada Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 6.4.2.3.1. Hospitals & Transplant Centers 6.4.2.3.2. Research Laboratories & Academic Institutes 6.4.2.3.3. Independent Reference Laboratories 6.4.2.3.4. Diagnostic Applications 6.4.3. Mexico 6.4.3.1. Mexico Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 6.4.3.1.1. Molecular Assays 6.4.3.1.2. Sequencing based molecular Assays 6.4.3.1.3. Non-Molecular Assays 6.4.3.2. Mexico Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 6.4.3.2.1. Solid Organ Transplantation 6.4.3.2.2. Soft Tissue Transplantation 6.4.3.2.3. Stem Cell Transplantation 6.4.3.3. Mexico Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 6.4.3.3.1. Hospitals & Transplant Centers 6.4.3.3.2. Research Laboratories & Academic Institutes 6.4.3.3.3. Independent Reference Laboratories 6.4.3.3.4. Diagnostic Applications 7. Europe Transplant Diagnostics Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 7.1. Europe Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.2. Europe Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.3. Europe Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4. Europe Transplant Diagnostics Market Size and Forecast, by Country (2023-2030) 7.4.1. United Kingdom 7.4.1.1. United Kingdom Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.1.2. United Kingdom Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.1.3. United Kingdom Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.2. France 7.4.2.1. France Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.2.2. France Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.2.3. France Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.3. Germany 7.4.3.1. Germany Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.3.2. Germany Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.3.3. Germany Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.4. Italy 7.4.4.1. Italy Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.4.2. Italy Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.4.3. Italy Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.5. Spain 7.4.5.1. Spain Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.5.2. Spain Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.5.3. Spain Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.6. Sweden 7.4.6.1. Sweden Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.6.2. Sweden Transplant Diagnostics Market Size and Forecast, by Ingredient (2023-2030) 7.4.6.3. Sweden Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.7. Austria 7.4.7.1. Austria Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.7.2. Austria Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.7.3. Austria Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 7.4.8. Rest of Europe 7.4.8.1. Rest of Europe Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 7.4.8.2. Rest of Europe Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 7.4.8.3. Rest of Europe Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8. Asia Pacific Transplant Diagnostics Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 8.1. Asia Pacific Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.2. Asia Pacific Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.3. Asia Pacific Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4. Asia Pacific Transplant Diagnostics Market Size and Forecast, by Country (2023-2030) 8.4.1. China 8.4.1.1. China Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.1.2. China Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.1.3. China Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4.2. S Korea 8.4.2.1. S Korea Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.2.2. S Korea Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.2.3. S Korea Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4.3. Japan 8.4.3.1. Japan Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.3.2. Japan Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.3.3. Japan Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4.4. India 8.4.4.1. India Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.4.2. India Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.4.3. India Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4.5. Australia 8.4.5.1. Australia Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.5.2. Australia Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.5.3. Australia Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4.6. ASEAN 8.4.6.1. ASEAN Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.6.2. ASEAN Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.6.3. ASEAN Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 8.4.7. Rest of Asia Pacific 8.4.7.1. Rest of Asia Pacific Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 8.4.7.2. Rest of Asia Pacific Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 8.4.7.3. Rest of Asia Pacific Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 9. South America Transplant Diagnostics Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 9.1. South America Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 9.2. South America Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 9.3. South America Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 9.4. South America Transplant Diagnostics Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 9.4.1.2. Brazil Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 9.4.1.3. Brazil Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 9.4.2.2. Argentina Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 9.4.2.3. Argentina Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 9.4.3.2. Rest Of South America Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 9.4.3.3. Rest Of South America Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 10. Middle East and Africa Transplant Diagnostics Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 10.1. Middle East and Africa Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 10.2. Middle East and Africa Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 10.3. Middle East and Africa Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 10.4. Middle East and Africa Transplant Diagnostics Market Size and Forecast, by Country (2023-2030) 10.4.1. South Africa 10.4.1.1. South Africa Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 10.4.1.2. South Africa Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 10.4.1.3. South Africa Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 10.4.2. GCC 10.4.2.1. GCC Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 10.4.2.2. GCC Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 10.4.2.3. GCC Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 10.4.3. Rest Of MEA 10.4.3.1. Rest Of MEA Transplant Diagnostics Market Size and Forecast, by Technology (2023-2030) 10.4.3.2. Rest Of MEA Transplant Diagnostics Market Size and Forecast, by Type (2023-2030) 10.4.3.3. Rest Of MEA Transplant Diagnostics Market Size and Forecast, by End User (2023-2030) 11. Company Profile: Key Players 11.1. Illumina, Inc. 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis (Technological strengths and weaknesses) 11.1.5. Strategic Analysis (Recent strategic moves) 11.1.6. Recent Developments 11.2. Thermo Fisher Scientific, Inc., 11.3. F. Hoffmann La-Roche AG., 11.4. Abbott Laboratories, Inc. 11.5. Qiagen N.V. 11.6. Bio-Rad Laboratories, Inc., 11.7. Siemens Healthineers (Siemens AG), 11.8. Becton, 11.9. Dickinson, and Company, 11.10. Immucor, Inc., 11.11. Qiagen N.V., 11.12. Agilent Technologies 11.13. Cylex Inc. 11.14. LXN Corporation 11.15. Alpha Laboratories 11.16. Horiba Medical 11.17. Laboratory Corporation of America Holdings 11.18. Randox Laboratories Ltd 11.19. Thermo Fisher Scientific Inc. 11.20. Otsuka Holdings Co Ltd. 11.21. Medtronic 11.22. Novartis AG 11.23. Pfizer Inc. 11.24. Sanofi 11.25. AbbVie Inc. 11.26. Stryker 11.27. Zimmer Biomet 11.28. Other Key Players 12. Key Findings and Analyst Recommendations 12.1. Attractive Opportunities for Players in the Transplant Diagnostics Market 13. Transplant Diagnostics Market: Research Methodology 13.1. Market Size Estimation 13.1.1. Bottom-Up approach 13.1.2. Top-Down approach 13.2. Data Triangulation and Market Breakdown 13.3. Growth Forecast 13.4. Risk Assessment

Global Transplant Diagnostics Market

Choose License Type